Preapheresis quantification of circulating CD34+ cells (CD34) may be used to predict peripheral blood progenitor cell (PBPC) yield in subsequent leukapheresis products. In this study, we ...
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma Allogeneic hematopoietic stem cell ...
Stem cells form the backbone of many cell-based therapies due to their unique properties, including the ability to self-renew and differentiate to many cell types. Multiple cell therapies deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback